A new type of cancer vaccine tested in mice appears to overcome some of the major hurdles associated with the treatment approach, according to a paper published today (November 25) in __Science Translational Medicine.__ The technology, which the researchers have already licensed to a biotechnology company, is being developed for clinical trials of melanoma.
The "reliable and careful" experiments shed light on a "promising approach" for a vaccine-based treatment for cancer, said linkurl:Eli Gilboa;http://biomed.miami.edu/?p=482&pid=206&m=facultyph&mid=1&item=200 a cancer immunologist from the University of Miami, who was not involved in the work. "It's a simple paper," he said, "in a good way." The new technology consists of a small sponge, the diameter of a pencil eraser, embedded with a vaccine and inserted under the...
released by the polymer matrix
(shown here) to sample the
tumor molecules embedded within.
Image: Edward Doherty, Omar Ali
and MicroVision Labs Inc.
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?